236 related articles for article (PubMed ID: 27004839)
1. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
[TBL] [Abstract][Full Text] [Related]
2. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
3. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
[TBL] [Abstract][Full Text] [Related]
4. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
5. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
[TBL] [Abstract][Full Text] [Related]
6. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
[TBL] [Abstract][Full Text] [Related]
8. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
9. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
10. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer.
Nakayama M; Tabuchi K; Hara A
Head Neck; 2015 Dec; 37(12):1745-9. PubMed ID: 24989115
[TBL] [Abstract][Full Text] [Related]
15. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer.
Kimura J; Kunisaki C; Makino H; Oshima T; Ota M; Oba M; Takagawa R; Kosaka T; Ono HA; Akiyama H; Endo I
Dis Esophagus; 2016 Nov; 29(8):1071-1080. PubMed ID: 26471766
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
Ide S; Toiyama Y; Okugawa Y; Oki S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Kusunoki M
Anticancer Res; 2017 Oct; 37(10):5797-5804. PubMed ID: 28982904
[TBL] [Abstract][Full Text] [Related]
18. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer.
Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y
Oncology; 2014; 87(4):205-14. PubMed ID: 25034097
[TBL] [Abstract][Full Text] [Related]
19. The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma.
Wen J; Bedford M; Begum R; Mitchell H; Hodson J; Whiting J; Griffiths E
J Surg Oncol; 2018 Jun; 117(8):1697-1707. PubMed ID: 29761518
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study.
Imaoka H; Mizuno N; Hara K; Hijioka S; Tajika M; Tanaka T; Ishihara M; Yogi T; Tsutsumi H; Fujiyoshi T; Sato T; Shimizu Y; Niwa Y; Yamao K
Pancreas; 2016 Feb; 45(2):211-7. PubMed ID: 26495775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
